CompletedNCT00517647
Atomoxetine for preschool children with ADHD
About this title
Read the official source — NCT00517647Medication studyAges 3–5United States
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 3 years to 5 years. Other eligibility criteria applied.
- Listed locations
- TucsonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 31
- Sponsor
- University of Arizona
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 3 Years to 5 Years
- Official registry ID
- NCT00517647
- Official title
Show the full official title
Atomoxetine Pilot Study in Preschool Children With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tucson
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Arizona, a university.
Did this study involve medication?
Yes. The study involved medication, including ATMX.
Who was this study for?
This study was for people with ADHD. Listed age limits: 3 years to 5 years. Other eligibility criteria applied.
